within Pharmacolibrary.Drugs.ATC.C;

model C09BA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.65,
    Cl             = 0.6666666666666666,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Captopril is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and some types of heart failure; when combined with diuretics, the mixture enhances blood pressure reduction by promoting excretion of water and salt. This fixed dose combination is approved and commonly used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for captopril and diuretic fixed-combination product in healthy adult volunteers (values mostly reflect captopril component, as diuretics vary depending on formulation).</p><h4>References</h4><ol><li>K L Duchin, D N McKinstry, A I Cohen, B H Migdalof,Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.,Clinical pharmacokinetics,1988<a href='https://pubmed.ncbi.nlm.nih.gov/3292102/'>https://pubmed.ncbi.nlm.nih.gov/3292102/</a></li><li>B H Migdalof, M J Antonaccio, D N McKinstry, S M Singhvi, S J Lan, P Egli, K J Kripalani,Captopril: pharmacology, metabolism and disposition.,Drug metabolism reviews,1984<a href='https://pubmed.ncbi.nlm.nih.gov/6437780/'>https://pubmed.ncbi.nlm.nih.gov/6437780/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09BA01;
